Critical Reviews in Immunology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.8 | Q4 | 16.9% | 0.558 | Q3 | 65.0% |
| 2024 | 0.9 | Q4 | 7.1% | 0.454 | Q3 | 59.1% |
| 2023 | 0.8 | Q4 | 6.1% | 0.409 | Q3 | 58.4% |
| 2022 | 1.3 | Q4 | 12.5% | 0.429 | Q3 | 61.4% |
| 2021 | 1.7 | Q4 | 20.8% | 0.663 | Q3 | 75.9% |
| 2020 | — | — | 0.997 | Q2 | 85.3% | |
| 2019 | — | — | 0.706 | Q3 | 77.1% | |
| 2018 | — | — | 0.657 | Q3 | 73.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1040-8401
country
UScoverage
1980-2026